Answer
Ramucirumab (Cyramza) with paclitaxel is indicated for adults with advanced gastric cancer or gastro-oesophageal junction adenocarcinoma whose disease has progressed after prior platinum and fluoropyrimidine chemotherapy.
Sources for this answer
- Cyramza 10 mg/ml concentrate for solution for infusionEli Lilly and Company Limited · emc · SmPC §4.1 Therapeutic Indications · Version 18Document updated
Sources checked